November 15, 2012 — The U.S. Food and Drug Administration (FDA) granted market clearance for Cook Medical’s Zilver PTX ...
Stents Peripheral
Peripheral stents are used to open narrow and hardening arteries that supply blood to the legs and feet.
October 23, 2012 — The use of stents for arterial blockages in the leg has been associated with high rates of late ...
October 23, 2012
October 15, 2012 — Three-year data from the Zilver PTX randomized controlled trial of paclitaxel-eluting stents for ...
October 15, 2012
October 8, 2012 — Following Health Canada approval, Cook Medical made the Zilver Vena Venous Self-Expanding Stent availa ...
October 08, 2012
September 27, 2012 — Boston Scientific has launched the Promus Element Plus BTK (Below The Knee) everolimus-eluting ...
September 27, 2012
August 22, 2012 — Placement of an endovascular stent has become a common procedure for successfully reopening blocked ...
August 22, 2012
August 15, 2012 — Previously unreleased three-year data from the Zilver PTX randomized controlled trial of paclitaxel ...
August 15, 2012
Aug. 8, 2012 — The U.S. Food and Drug Administration (FDA) has approved Abbott’s Omnilink Elite Vascular Balloon ...
August 08, 2012July 12, 2012 — Terumo Interventional Systems, a strategic business unit of Terumo Medical Corporation, a U.S ...
July 12, 2012July 3, 2012 — Flexible Stenting Solutions Inc., a leading developer of next generation peripheral arterial, venous ...
July 03, 2012
May 23, 2012 - Boston Scientific Corp. announces U.S. Food and Drug Administration approval and market launch of the ...
May 23, 2012May 17, 2012 — Boston Scientific Corp. announces CE mark and European market launch of the Innova Self-Expanding Bare ...
May 17, 2012
March 16, 2012 — The U.S. Food and Drug Administration (FDA) approved the premarket approval (PMA) application for the ...
March 16, 2012
March 6, 2012 — In a development that brings advanced combination therapy treatment of peripheral artery disease (PAD) t ...
March 06, 2012January 18, 2012 — Boston Scientific reported nine-month clinical endpoint data from its ORION trial, demonstrating ...
January 18, 2012© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now